Hangzhou Sciwind Biosciences, a biopharmaceutical company focused on the discovery and development of innovative therapies for metabolic diseases, today announced that China's National Medical ...

According to J&J, this approval offers a potential new standard of care (SOC) as early as second line and brings a novel ...

Servier, a French independent international pharmaceutical group governed by a foundation, today announced that it has entered into a definitive agreement to acquire Day One Biopharmaceuticals for $21 ...

Seattle-based Nautilus Biotechnology, a specialist in single-molecule proteome analysis, has announced the appointment of Amber Faust as vice president of sales.

Shares of US clinical-stage biotech Tenaya Therapeutics closed up more than 40% at $0.82 yesterday following its announcement of a potentially lucrative collaboration.

Cambridge, USA-based precision allosteric therapeutics biotech Atavistik Bio has announced the closing of a $40 million ...

Swedish specialty pharma Orexo is reorganizing its management team as it pivots away from direct US commercialization ...

Swiss pharma Roche (ROG: SIX) reported positive Phase II results for its investigational amylin analog petrelintide, showing meaningful weight loss and a placebo-like tolerability profile in people ...

US drugmaker Vertex Pharmaceuticals today announced data from a Phase IV study of Journavx (suzetrigine), a prescription ...

The Accelerating Clinical Trials in the EU (ACT EU) initiative has published a draft guidance document outlining how clinical ...

A pre-clinical biopharmaceutical company dedicated to precision cardiology through targeted RNA therapeutics designed to ...

I've worked with pharmaceutical companies for years, and one pattern keeps repeating: the most significant environmental, health, and safety (EHS) risks are rarely dramatic. They sit in routine ...